de Bessemer Group Charles River Laboratories CRL Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | USD 6.16 M | Vender |
20,881
-2,071
| -9% | -USD 546 k | 0.01% | 506 |
|
|
2026
Q2 | USD 5.21 M | Vender |
22,952
-1
| -0% | -USD 178 | 0.01% | 563 |
|
|
2026
Q1 | USD 3.96 M | Vender |
22,953
-405
| -2% | -USD 75.1 k | 0.01% | 562 |
|
|
2025
Q4 | USD 4.66 M | Comprar |
23,358
+18,322
| +364% | +USD 3.32 M | 0.01% | 435 |
|
|
2025
Q3 | USD 788 k | Comprar |
5,036
+458
| +10% | +USD 72.7 k | ﹤0.01% | 721 |
|
|
2025
Q2 | USD 694 k | Vender |
4,578
-2,357
| -34% | -USD 314 k | ﹤0.01% | 727 |
|
|
2025
Q1 | USD 1.04 M | Vender |
6,935
-16,538
| -70% | -USD 2.77 M | ﹤0.01% | 682 |
|
|
2024
Q4 | USD 4.33 M | Vender |
23,473
-3
| -0% | -USD 578 | 0.01% | 450 |
|
|
2024
Q3 | USD 4.62 M | Comprar |
23,476
+14,818
| +171% | +USD 3.08 M | 0.01% | 447 |
|
|
2024
Q2 | USD 1.79 M | Comprar |
8,658
+9
| +0.1% | +USD 2.04 k | ﹤0.01% | 529 |
|
|
2024
Q1 | USD 2.34 M | Comprar |
8,649
+7,095
| +457% | +USD 1.69 M | ﹤0.01% | 498 |
|
|
2023
Q4 | USD 367 k | Vender |
1,554
-80
| -5% | -USD 15.7 k | ﹤0.01% | 909 |
|
|
2023
Q3 | USD 320 k | Vender |
1,634
-33
| -2% | -USD 6.78 k | ﹤0.01% | 923 |
|
|
2023
Q2 | USD 351 k | Comprar |
1,667
+404
| +32% | +USD 80.4 k | ﹤0.01% | 902 |
|
|
2023
Q1 | USD 255 k | Vender |
1,263
-61
| -5% | -USD 13.8 k | ﹤0.01% | 860 |
|
|
2022
Q4 | USD 289 k | Comprar |
1,324
+601
| +83% | +USD 131 k | ﹤0.01% | 825 |
|
|
2022
Q3 | USD 142 k | Vender |
723
-247
| -25% | -USD 53.3 k | ﹤0.01% | 956 |
|
|
2022
Q2 | USD 208 k | Vender |
970
-760
| -44% | -USD 186 k | ﹤0.01% | 872 |
|
|
2022
Q1 | USD 491 k | Vender |
1,730
-260
| -13% | -USD 80.2 k | ﹤0.01% | 644 |
|
|
2021
Q4 | USD 749 k | Vender |
1,990
-267
| -12% | -USD 104 k | ﹤0.01% | 524 |
|
|
2021
Q3 | USD 931 k | Comprar |
2,257
+8
| +0.4% | +USD 3.32 k | ﹤0.01% | 432 |
|
|
2021
Q2 | USD 832 k | Comprar |
2,249
+858
| +62% | +USD 286 k | ﹤0.01% | 453 |
|
|
2021
Q1 | USD 403 k | Vender |
1,391
-445
| -24% | -USD 124 k | ﹤0.01% | 596 |
|
|
2020
Q4 | USD 458 k | Comprar |
1,836
+68
| +4% | +USD 16.2 k | ﹤0.01% | 550 |
|
|
2020
Q3 | USD 400 k | Vender |
1,768
-107
| -6% | -USD 22.2 k | ﹤0.01% | 553 |
|
|
2020
Q2 | USD 327 k | Mantener |
1,875
| – | – | ﹤0.01% | 1055 |
|
|
2020
Q1 | USD 237 k | Comprar |
1,875
+440
| +31% | +USD 66 k | ﹤0.01% | 951 |
|
|
2019
Q4 | USD 219 k | Mantener |
1,435
| – | – | ﹤0.01% | 1058 |
|
|
2019
Q3 | USD 190 k | Mantener |
1,435
| – | – | ﹤0.01% | 1069 |
|
|
2019
Q2 | USD 204 k | Vender |
1,435
-89
| -6% | -USD 12.1 k | ﹤0.01% | 1074 |
|
|
2019
Q1 | USD 221 k | Vender |
1,524
-155
| -9% | -USD 20.4 k | ﹤0.01% | 972 |
|
|
2018
Q4 | USD 190 k | Vender |
1,679
-81
| -5% | -USD 10.1 k | ﹤0.01% | 992 |
|
|
2018
Q3 | USD 237 k | Mantener |
1,760
| – | – | ﹤0.01% | 950 |
|
|
2018
Q2 | USD 198 k | Mantener |
1,760
| – | – | ﹤0.01% | 984 |
|
|
2018
Q1 | USD 188 k | Mantener |
1,760
| – | – | ﹤0.01% | 1014 |
|
|
2017
Q4 | USD 193 k | Mantener |
1,760
| – | – | ﹤0.01% | 1025 |
|
|
2017
Q3 | USD 190 k | Mantener |
1,760
| – | – | ﹤0.01% | 1071 |
|
|
2017
Q2 | USD 178 k | Vender |
1,760
-130
| -7% | -USD 12 k | ﹤0.01% | 1083 |
|
|
2017
Q1 | USD 170 k | Vender |
1,890
-43
| -2% | -USD 3.65 k | ﹤0.01% | 1127 |
|
|
2016
Q4 | USD 147 k | Comprar |
1,933
+43
| +2% | +USD 3.27 k | ﹤0.01% | 1148 |
|
|
2016
Q3 | USD 158 k | Mantener |
1,890
| – | – | ﹤0.01% | 1026 |
|
|
2016
Q2 | USD 156 k | Mantener |
1,890
| – | – | ﹤0.01% | 699 |
|
|
2016
Q1 | USD 144 k | Vender |
1,890
-19,227
| -91% | -USD 1.42 M | ﹤0.01% | 724 |
|
|
2015
Q4 | USD 1.7 M | Comprar |
21,117
+555
| +3% | +USD 40 k | 0.01% | 462 |
|
|
2015
Q3 | USD 1.31 M | Comprar |
20,562
+19,227
| +1,440% | +USD 1.38 M | 0.01% | 510 |
|
|
2015
Q2 | USD 94 k | Mantener |
1,335
| – | – | ﹤0.01% | 858 |
|
|
2015
Q1 | USD 106 k | Vender |
1,335
-465
| -26% | -USD 34.3 k | ﹤0.01% | 814 |
|
|
2014
Q4 | USD 115 k | Mantener |
1,800
| – | – | ﹤0.01% | 782 |
|
|
2014
Q3 | USD 108 k | Mantener |
1,800
| – | – | ﹤0.01% | 764 |
|
|
2014
Q2 | USD 96 k | Mantener |
1,800
| – | – | ﹤0.01% | 776 |
|
|
2014
Q1 | USD 109 k | Vender |
1,800
-200
| -10% | -USD 11.7 k | ﹤0.01% | 720 |
|
|
2013
Q4 | USD 107 k | Mantener |
2,000
| – | – | ﹤0.01% | 727 |
|
|
2013
Q3 | USD 93 k | Vender |
2,000
-225
| -10% | -USD 10.3 k | ﹤0.01% | 734 |
|
|
2013
Q2 | USD 91 k | Comprar |
+2,225
| Nuevas | +USD 95.3 k | ﹤0.01% | 664 |
|
Otros fondos que tienen CRL en su cartera
Posición de Bessemer Group en CRL: resumen de T3 2026
Bessemer Group redujo su participación en Charles River Laboratories (CRL) en 9% durante T3 2026, al vender acciones por un valor estimado de USD 546 k, y conservó 20,881 acciones valuadas en USD 6.16 M. La posición representa 0.01% de la cartera y ocupa el puesto #506.
Bessemer Group reportó por primera vez una posición en CRL en T2 2013 y la ha mantenido durante 54 trimestres desde entonces. Al cierre de T3 2026, 515 fondos que sigue Wall St. Rank mantienen una posición en CRL.
- Al cierre de T3 2026, Bessemer Group tenía 20,881 acciones de Charles River Laboratories con un valor de USD 6.16 M.
- Bessemer Group vendió 2,071 acciones de Charles River Laboratories en T3 2026, por un valor estimado de USD 546 k.
- Charles River Laboratories representó 0.01% de la cartera de Bessemer Group en T3 2026 y fue su posición número 506.
- Bessemer Group reportó por primera vez una posición en Charles River Laboratories en T2 2013 y la ha mantenido durante 54 trimestres desde entonces.
- Al cierre de T3 2026, 515 fondos que sigue Wall St. Rank tenían Charles River Laboratories en cartera.
Según el Informe 13F de Bessemer Group correspondiente a T3 2026, presentado el 9 nov 2026.